Clinical Trial

TIS for Drug Resistant TLE

Study acronym: TITE-Effect
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Temporal interference (TI) stimulation is a new neuromodulation method. Compared with traditional neuromodulation therapy, TI has deep targeting and focusing, and it has been confirmed to modulate sleep, cognition, and movement disorders. Recent study shown that TI stimulation targeting the hippocampus could significantly reduce epileptiform discharges, but its efficacy on seizures was still unclear. Therefore, the aim of this study is to observe the therapeutic effect of TI stimulation targeting the hippocampus in patients with refractory temporal lobe epilepsy (TLE) for 5 days, and to provide support for clinical trials of non-invasive treatment of refractory TLE.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-15
Trial Details
NCT Number NCT07519018
Lead Sponsor Xijing Hospital
Conditions Epilepsy
Enrollment 30 participants
Start Date 2026-04-15
Primary Completion 2027-04-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14